Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Avandia on Bone in Postmenopausal Women with Type 2 Diabetes Mellitus
2008-002301-38Phase 4Completed
- Sponsor
- GSK
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of rosiglitazone in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by GSK. Started Jun 2008; status: completed.
02
Drugs
rosiglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-002301-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002301-38.